MORE►
Colossal
Colossal Foundation Executive Director Matt James (center) with Colossal's head of animal husbandry, Steve Metzler, and Wendy Kiso, Colossal's principal scientist for assisted reproduction. [Photo: Colossal}
Colossal Launches The Colossal Foundation with $50M for ‘BioVault’ Biobanking, Genetic Rescues, and More
by Lance Murray | Oct 1, 2024
The North Texas-based foundation aims to fight the "extinction crisis" with initiatives including Colossal Biovault—"the world's largest distributed biobanking initiative"—and an array of new efforts to both preserve and "de-extinct" wildlife.
by Nicole Ward, DRC Data Journalist |
Aug 14, 2024
Carter Inc. aims to be the first call for both corporate and high-stakes biotech relocations, working to keep transitions smooth and operations on track.
MORE►
by Glenn Hunter |
May 2, 2024
Dallas Innovates, the Dallas Regional Chamber, and Dallas AI have teamed up to launch the inaugural AI 75 list. The 2024 program honors the most significant people in AI in DFW in seven categories—the visionaries, creators, and influencers you need to know.
MORE►
by Lance Murray |
Apr 17, 2024
Colossal Biosciences’ academic investments include partnerships with Stockholm University, the University of Potsdam, the University of California Santa Cruz, the University of Alaska, McMaster University, University of Copenhagen, and Rowan University, among others.
MORE►
The Victorian Grassland Earless Dragon [Photo: Zoos Victoria]
Here Be Dragons: Colossal Partners with Zoos Victoria To Save Reptile Once Thought Extinct
by David Seeley | Oct 25, 2023
OK, it may not be as big—or as fire-breathing—as the dragons that swooped over Westeros on "Game of Thrones." But Australia's Victorian Grassland Earless Dragon is every bit as magical for simply hanging in there, decades after many thought it was extinct. Now Texas-based Colossal Biosciences is partnering to help preserve it—and sequence its genome.
MORE►
by Quincy Preston and Lance Murray |
Sep 19, 2023
With only two known living female northern white rhinos left, Colossal Biosciences and BioRescue have joined forces to fend off a looming extinction of the species. At the cutting edge of science, they're harnessing genetic technologies to rewrite the rhino's fate.
MORE►
by Dallas Innovates | Staff Report |
Mar 1, 2023
Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem....
MORE►
by Lance Murray |
Jan 17, 2023
Dallas Innovates and D CEO celebrated 68 honorees and revealed the winners of our fourth-annual Innovation Awards at an event held at On the Levee in the Dallas Design District.
Here's a full list of winners and finalists.
MORE►
Colossal Biosciences co-founders Ben Lamm and George Church aim to "de-extinct" the woolly mammoth and other long-lost creatures. [Photo: Colossal]
Mammoth Interest: The CIA Invests in Dallas-Based Colossal Biosciences
by David Seeley | Oct 11, 2022
The Central Intelligence Agency has invested in Colossal through its nonprofit VC investment arm, In-Q-Tel, reports The Intercept. Named in honor of Q—the tech genius from the James Bond novels and movies—the VC firm was founded in 1999 to keep U.S. intelligence agencies on the cutting edge of "innovative and impactful technologies coming out of Silicon Valley and beyond."
So why Colossal? "Strategically, it’s less about the mammoths and more about the capability," In-Q-Tel says.
MORE►
by Kevin Cummings |
Sep 26, 2022
After a rigorous process, the top six applications to the Tech Transfer Office Showcase at BioNTX's iC3 life science summit were invited to pitch live at BioNTX's life science summit. Industry experts rated, graded, and discussed the technologies prior to the pitches
"We want to cultivate technologies that are coming out of the university ecosystem here—and we want them to stay here," said Chad Ronholdt, managing director at NVB Ventures.
MORE►
by Quincy Preston and David Seeley |
Mar 9, 2022
Colossal launched last September with a plan to "de-extinct" the woolly mammoth by using CRISPR genetic engineering to create a mammoth-elephant hybrid.
With a total raise of $75 million to date, the startup aims to
have its first set of mammoth-elephant hybrid calves "in 4 to 6 years," co-founder and CEO Ben Lamm told us. But Colossal's goals extend much further—with the potential "to advance human health, enhance food production, reduce environmental impact, and optimize animal health and welfare."
MORE►
by David Seeley |
Dec 3, 2021
The Eos—a refrigerator-sized green energy solution powered by machine intelligence—captures and sequesters carbon from the atmosphere using algae. Hypergiant founder Ben Lamm, who's trying to bring back the woolly mammoth with his new startup Colossal, looks back at the development of Eos, and what it could mean for the world.
MORE►
